SKBI

Skystar’s New Vaccine Facility in Huxian Passes Initial GMP Certification

[at noodls] – New Vaccine Facility Includes Animal and Aquaculture Vaccine Lines; At Maximum Potential Production Capacity, the New Facility Is Projected to Be Capable of Manufacturing an Estimated $15 Million to $17 … moreView todays social media effects on SKBIView the latest stocks trending across Twitter. Click to view dashboard […]

Skystar’s Primary Veterinary Medication Facility in Huxian Province Resumes Production and Distribution

[at noodls] – Skystar’s Primary Veterinary Medication Facility in Huxian Province Resumes Production and Distribution XI’AN, CHINA — (Marketwire) — 11/05/12 — Skystar Bio-Pharmaceutical Company(NASDAQ: SKBI) (Skystar … moreView todays social media effects on SKBIView the latest stocks trending across Twitter. Click to view dashboard […]